Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Drugs in pregnancy

Drugs in pregnancy Downloaded from http://journals.lww.com/adversedrugreactbull by BhDMf5ePHKbH4TTImqenVJ2toCr/9wZZjwPUWvYES9l2nY+zyylnl33NGMK6MRsx on 10/02/2020 April 2020 No. 321 Founded in 1966 by Professor D M Davies, FRCP, FRCP Ed ISSN 0044–6394 Risk assessment Assessing the fetal risk of a drug causing malformation is complicated by the fact that a,b c Jon T. Andersen & Tina Bergmann Futtrup the background risk of a child being born Department of Clinical Pharmacology, Copenhagen University Hospital Bispebjerg, with a major congenital malformation is Institute of Clinical Medicine, Faculty of Medical and Health Science, University of 3.5%, and most often without a known Copenhagen, Copenhagen and Department of Obstetrics and Gynecology, Copenhagen cause. Based on this, it can be statistically University Hospital North Zealand, Hillerød, Denmark estimated that 200 pregnancies exposed to a Correspondence to Jon T. Andersen, MD, PhD, chief physician, associated professor, drug during the 1st trimester provide enough Department of Clinical Pharmacology, Copenhagen University Hospital Bispebjerg, power (80% strength and 5% significance Bispebjerg Bakke 23, DK-2400 Copenhagen, Denmark. Tel.: +45 2972 1508; level) to exclude an increased risk of more e-mail: jon.thor.traerup.andersen@regionh.dk than three times higher than the background risk; 700 exposed provide enough power (80% strength and 5% significance level) to exclude an increased risk of more http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Adverse Drug Reaction Bulletin Wolters Kluwer Health

Drugs in pregnancy

Download PDF
4 pages

Loading next page...
 
/lp/wolters-kluwer-health/drugs-in-pregnancy-OgL1GcP4Ar

References (26)

Publisher
Wolters Kluwer Health
Copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
ISSN
0044-6394
eISSN
2159-7774
DOI
10.1097/FAD.0000000000000047
Publisher site
See Article on Publisher Site

Abstract

Downloaded from http://journals.lww.com/adversedrugreactbull by BhDMf5ePHKbH4TTImqenVJ2toCr/9wZZjwPUWvYES9l2nY+zyylnl33NGMK6MRsx on 10/02/2020 April 2020 No. 321 Founded in 1966 by Professor D M Davies, FRCP, FRCP Ed ISSN 0044–6394 Risk assessment Assessing the fetal risk of a drug causing malformation is complicated by the fact that a,b c Jon T. Andersen & Tina Bergmann Futtrup the background risk of a child being born Department of Clinical Pharmacology, Copenhagen University Hospital Bispebjerg, with a major congenital malformation is Institute of Clinical Medicine, Faculty of Medical and Health Science, University of 3.5%, and most often without a known Copenhagen, Copenhagen and Department of Obstetrics and Gynecology, Copenhagen cause. Based on this, it can be statistically University Hospital North Zealand, Hillerød, Denmark estimated that 200 pregnancies exposed to a Correspondence to Jon T. Andersen, MD, PhD, chief physician, associated professor, drug during the 1st trimester provide enough Department of Clinical Pharmacology, Copenhagen University Hospital Bispebjerg, power (80% strength and 5% significance Bispebjerg Bakke 23, DK-2400 Copenhagen, Denmark. Tel.: +45 2972 1508; level) to exclude an increased risk of more e-mail: jon.thor.traerup.andersen@regionh.dk than three times higher than the background risk; 700 exposed provide enough power (80% strength and 5% significance level) to exclude an increased risk of more

Journal

Adverse Drug Reaction Bulletin – Wolters Kluwer Health

Published: Apr 1, 2020

There are no references for this article.